Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level
Soft tissue sarcomas (STSs) are a heterogeneous group of rare tumors. Although constituting only 1% of all human malignancies, STSs represent the second most common type of solid tumors in children and adolescents and comprise an important group of secondary malignancies. Over 100 histologic subtype...
Main Authors: | Serena Pillozzi, Andrea Bernini, Ilaria Palchetti, Olivia Crociani, Lorenzo Antonuzzo, Domenico Campanacci, Guido Scoccianti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/12/3044 |
Similar Items
-
Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma
by: Boran Pang, et al.
Published: (2021-06-01) -
Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma
by: Zhengjun Lin, et al.
Published: (2021-09-01) -
Pulmonary metastasectomy from soft tissue sarcomas
by: Rodrigo Afonso da Silva Sardenberg, et al.
Published: (2010-01-01) -
Oncological outcome and prognostic factors in the therapy of soft tissue sarcoma of the extremities
by: Ingmar Ipach, et al.
Published: (2012-11-01) -
A seven-lncRNA signature for predicting Ewing’s sarcoma
by: Zhihui Chen, et al.
Published: (2021-06-01)